Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Nanodrug regulates lactic acid metabolism to reprogram the immunosuppressive tumor microenvironment for enhanced cancer immunotherapy
Li-Rong Tian, Minzhao Lin, Huihai Zhong, et al.
Biomaterials Science (2022) Vol. 10, Iss. 14, pp. 3892-3900
Closed Access | Times Cited: 31

Showing 1-25 of 31 citing articles:

Metabolism, metabolites, and macrophages in cancer
Mengyuan Li, Yuhan Yang, Liting Xiong, et al.
Journal of Hematology & Oncology (2023) Vol. 16, Iss. 1
Open Access | Times Cited: 161
Managing the immune microenvironment of osteosarcoma: the outlook for osteosarcoma treatment
Hailong Tian, Jiangjun Cao, Bowen Li, et al.
Bone Research (2023) Vol. 11, Iss. 1
Open Access | Times Cited: 106
Engineering lactate-modulating nanomedicines for cancer therapy
Jiajie Chen, Yufang Zhu, Chengtie Wu, et al.
Chemical Society Reviews (2023) Vol. 52, Iss. 3, pp. 973-1000
Closed Access | Times Cited: 49
NK cell-based tumor immunotherapy
Hao Zhang, Yang Li, Tingting Wang, et al.
Bioactive Materials (2023) Vol. 31, pp. 63-86
Open Access | Times Cited: 48
Programmed Targeting Pyruvate Metabolism Therapy Amplified Single‐Atom Nanozyme‐Activated Pyroptosis for Immunotherapy
Rui Niu, Yang Liu, Bo Xu, et al.
Advanced Materials (2024) Vol. 36, Iss. 24
Closed Access | Times Cited: 43
Lactate and lactylation in cancer
Jie Chen, Ziyue Huang, Ya Chen, et al.
Signal Transduction and Targeted Therapy (2025) Vol. 10, Iss. 1
Open Access | Times Cited: 12
Nanomedicines Targeting Metabolic Pathways in the Tumor Microenvironment: Future Perspectives and the Role of AI
Shuai Fan, Wenyu Wang, Wieqi Che, et al.
Metabolites (2025) Vol. 15, Iss. 3, pp. 201-201
Open Access | Times Cited: 2
Current Advances on Nanomaterials Interfering with Lactate Metabolism for Tumor Therapy
Qian Cheng, Xiao‐Lei Shi, Qilin Li, et al.
Advanced Science (2023) Vol. 11, Iss. 3
Open Access | Times Cited: 23
MCT4-driven CAF-mediated metabolic reprogramming in breast cancer microenvironment is a vulnerability targetable by miR-425-5p
Alessandra Affinito, Cristina Quintavalle, Rosario Vincenzo Chianese, et al.
Cell Death Discovery (2024) Vol. 10, Iss. 1
Open Access | Times Cited: 12
The Impact of Metabolic Rewiring in Glioblastoma: The Immune Landscape and Therapeutic Strategies
Yuganthini Vijayanathan, Ivy A. W. Ho
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 2, pp. 669-669
Open Access | Times Cited: 1
Modulation of glucose metabolism through macrophage-membrane-coated metal-organic framework nanoparticles for triple-negative breast cancer therapy
Qing Yao, Jinyao Ye, Yahui Chen, et al.
Chemical Engineering Journal (2023) Vol. 480, pp. 148069-148069
Closed Access | Times Cited: 17
Biodegradable copper peroxide decorated hollow polydopamine nanocomposite as effective chloroperoxidase delivery carrier for enhancing enzyme dynamic therapy via self-activated cascade reactions
Weiwei Wu, Yan Yang, Yu Zhang, et al.
Chemical Engineering Journal (2023) Vol. 481, pp. 148113-148113
Closed Access | Times Cited: 14
PEG‐Sheddable Nanodrug Remodels Tumor Microenvironment to Promote Effector T Cell Infiltration and Revise Their Exhaustion for Breast Cancer Immunotherapy
Tao Huang, Qiaoyun Zhang, Jing Yi, et al.
Small (2023) Vol. 19, Iss. 38
Closed Access | Times Cited: 11
Reprogramming of Glucose Metabolism by Nanocarriers to Improve Cancer Immunotherapy: Recent Advances and Applications
Kehua Jiang, Hongming Liu, Xiaolong Chen, et al.
International Journal of Nanomedicine (2025) Vol. Volume 20, pp. 4201-4234
Open Access
Advanced Biomaterials with Intrinsic Immunomodulation Effects for Cancer Immunotherapy
Weizhi Chen, Cheng Li, Xiqun Jiang
Small Methods (2023) Vol. 7, Iss. 5
Closed Access | Times Cited: 9
Nanomaterials-involved strategies for reversing the immunosuppressive factors and improving antitumor immunotherapy
Fan Gao, JianHui Dong, Chun Xue, et al.
Nano Today (2023) Vol. 50, pp. 101831-101831
Closed Access | Times Cited: 9
The emerging roles of metabolism in the crosstalk between breast cancer cells and tumor-associated macrophages
Yuxin Liang, Jun He, Xiguang Chen, et al.
International Journal of Biological Sciences (2023) Vol. 19, Iss. 15, pp. 4915-4930
Open Access | Times Cited: 9
Smart Design of Nanostructures for Boosting Tumor Immunogenicity in Cancer Immunotherapy
Bohan Yin, Wai‐Ki Wong, Yip-Ming Ng, et al.
Pharmaceutics (2023) Vol. 15, Iss. 5, pp. 1427-1427
Open Access | Times Cited: 8
Enhancing melanoma therapy by modulating the immunosuppressive microenvironment with an MMP-2 sensitive and nHA/GNE co-encapsulated hydrogel
Zhu Chen, Hongfeng Wu, Yifu Wang, et al.
Acta Biomaterialia (2024)
Closed Access | Times Cited: 3
Tiliroside suppresses triple-negative breast cancer as a multifunctional CAXII inhibitor
Rui Han, Hongxing Yang, Changquan Ling, et al.
Cancer Cell International (2022) Vol. 22, Iss. 1
Open Access | Times Cited: 13
Advanced nanomaterials for enhanced immunotherapy via metabolic regulation
Xinyang Li, Binbin Ding, Pan Zheng, et al.
Coordination Chemistry Reviews (2023) Vol. 500, pp. 215540-215540
Closed Access | Times Cited: 8
An enzyme-instructed self-assembly system induces tumor acidosis via sequential-dual effect for cancer selective therapy
Hao Zhang, Zhilong Wang, Tongxin Gao, et al.
Acta Biomaterialia (2023) Vol. 164, pp. 447-457
Closed Access | Times Cited: 7
Innovative lipid nanoparticles: A cutting-edge approach for potential renal cell carcinoma therapeutics
Asif Shahzad, Zhuoran Teng, Muhammad Arfat Yameen, et al.
Biomedicine & Pharmacotherapy (2024) Vol. 180, pp. 117465-117465
Open Access | Times Cited: 2
The effect of lactate dehydrogenase inhibitors on proliferation, motility and invasion of breast cancer cells in vitro highlights a new role for lactate
Maitham A. Khajah, Sarah Khushaish, Yunus A. Luqmani
Molecular Medicine Reports (2023) Vol. 29, Iss. 1
Open Access | Times Cited: 5
Nano-medicine therapy reprogramming metabolic network of tumour microenvironment: new opportunity for cancer therapies
Xiaojie Zhang, Min An, Juntao Zhang, et al.
Journal of drug targeting (2024) Vol. 32, Iss. 3, pp. 241-257
Closed Access | Times Cited: 1
Page 1 - Next Page

Scroll to top